Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Biosimilars V 2.0

Biosimilars: SOP for Filter Integrity Testing in Bioreactor Operations – V 2.0

Posted on By

To establish a standard procedure for performing integrity testing of sterile filters used in bioreactor operations for biosimilar manufacturing. This ensures the filter maintains microbial retention capacity and complies with GMP requirements.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Cross-Contamination Control in Bioreactor Operations – V 2.0

Posted on By

To define systematic measures for controlling cross-contamination in bioreactor operations during biosimilar manufacturing. The SOP ensures implementation of controls to avoid cross-mixing of products, microbial ingress, or carryover of residues between batches or processes.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Pressure Vessel Safety Checks in Bioreactor Operations – V 2.0

Posted on By

To define the standard procedure for conducting safety checks, inspection, and preventive maintenance of pressure vessels used in biosimilar bioreactor operations. This SOP ensures all pressure-bearing equipment complies with safety and regulatory standards to avoid risk to personnel and product.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Temperature Mapping of Bioreactor Jackets – V 2.0

Posted on By

To establish a validated method for temperature mapping of bioreactor jackets to confirm uniform heat transfer across the vessel surface, ensuring optimal growth conditions for biosimilar production processes and compliance with GMP guidelines.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Calibration of pH and DO Sensors in Bioreactor Operations – V 2.0

Posted on By

To outline the standardized procedure for calibration of pH and dissolved oxygen (DO) sensors used in bioreactor operations for biosimilar production. This ensures sensors function accurately to support optimal cell culture conditions.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Inline Analytics (Raman, NIR) in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for using inline Raman and Near Infrared (NIR) spectroscopy systems in bioreactor operations for real-time monitoring of critical process parameters (CPPs) in biosimilar manufacturing.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Sterile Addition of Feeds and Supplements in Bioreactor Operations – V 2.0

Posted on By

To establish a validated, sterile method for the addition of feeds, buffers, and supplements to bioreactor systems during biosimilar production. This ensures aseptic conditions and prevents contamination that could compromise batch quality.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Cleaning and Sanitization of Bioreactors – V 2.0

Posted on By

To define the validated cleaning and sanitization procedures for bioreactors used in biosimilar manufacturing, ensuring removal of residues and microbial control in accordance with cGMP standards.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Media Hold Time Validation in Bioreactor Operations – V 2.0

Posted on By

To define the procedure for validating the acceptable hold time of cell culture media prior to inoculation in bioreactor operations, ensuring the media retains its sterility and nutrient composition throughout the defined period.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Use of Single-Use Bioreactor Systems – V 2.0

Posted on By

To define the standard procedure for the preparation, operation, and disposal of single-use bioreactor (SUB) systems used in biosimilar manufacturing, ensuring aseptic processing and operational consistency.
Click to read the full article.

Biosimilars V 2.0

Posts pagination

Previous 1 … 9 10 11 … 20 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme